Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kuruvilla

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
The Lancet. Oncology|June 9, 2020
Developing anti-CD19 antibody-based combinations in lymphomaJohn Kuruvilla
The Lancet. Oncology|June 4, 2021
Pembrolizumab for relapsed or refractory Hodgkin lymphoma - Author's replyJohn Kuruvilla,
Blood|March 19, 2016
The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphomaJohn Kuruvilla
Blood|June 1, 2023
Targeted therapy in mediastinal gray zone lymphomaJohn Kuruvilla
Hematology. American Society of Hematology. Education Program|December 17, 2009
Standard therapy of advanced Hodgkin lymphomaJohn Kuruvilla
Blood Reviews|May 1, 2012
Treatment of newly diagnosed advanced stage Hodgkin lymphomaJieun Uhm, John Kuruvilla
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 10, 2013
Relapsed and refractory aggressive NHL: time for a changeShane Gangatharan, John Kuruvilla
Current Opinion in Hematology|August 24, 2017
Autologous hematopoietic cell transplantation of mantle cell lymphoma: emerging trendsUmberto Falcone, John Kuruvilla
JCO Oncology Practice|February 10, 2021
Addressing an Unmet Need in Relapsed or Refractory Hodgkin LymphomaSemira Sheikh, John Kuruvilla
Leukemia & Lymphoma|December 28, 2020
Evolving management strategies for lymphomas during the COVID-19 pandemicNoemie Lang, John Kuruvilla
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
The Lancet. Oncology|June 9, 2020
Developing anti-CD19 antibody-based combinations in lymphomaJohn Kuruvilla
The Lancet. Oncology|June 4, 2021
Pembrolizumab for relapsed or refractory Hodgkin lymphoma - Author's replyJohn Kuruvilla,
Blood|March 19, 2016
The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphomaJohn Kuruvilla
Blood|June 1, 2023
Targeted therapy in mediastinal gray zone lymphomaJohn Kuruvilla
Hematology. American Society of Hematology. Education Program|December 17, 2009
Standard therapy of advanced Hodgkin lymphomaJohn Kuruvilla
Blood Reviews|May 1, 2012
Treatment of newly diagnosed advanced stage Hodgkin lymphomaJieun Uhm, John Kuruvilla
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 10, 2013
Relapsed and refractory aggressive NHL: time for a changeShane Gangatharan, John Kuruvilla
Current Opinion in Hematology|August 24, 2017
Autologous hematopoietic cell transplantation of mantle cell lymphoma: emerging trendsUmberto Falcone, John Kuruvilla
JCO Oncology Practice|February 10, 2021
Addressing an Unmet Need in Relapsed or Refractory Hodgkin LymphomaSemira Sheikh, John Kuruvilla
Leukemia & Lymphoma|December 28, 2020
Evolving management strategies for lymphomas during the COVID-19 pandemicNoemie Lang, John Kuruvilla
Pageof 21